首页 | 本学科首页   官方微博 | 高级检索  
     


Surgical management of intractable interstitial cystitis
Authors:Dr G. Zhang  D. Kappor  A. Sidi
Affiliation:(1) Department of Urologic Surgery, University of Minnesota Hospitals and Clinic, Minneapolis, Minnesota, USA;(2) Urology Section (112D), VA Medical Center, One Veterans Drive, 55417 Minneapolis, MN, USA
Abstract:
Interstitial cystitis represents a diagnostic and therapeutic challenge. Most patients can be managed conservatively, but a small number of patients do not respond to conservative therapy and for them surgical treatment is indicated. This article reviews the historical and currently used surgical modalities. Enterocystoplasty is the surgical treatment of choice for intractable interstitial cystitis. The results of enterocystoplasty are satisfactory in approximately 80% of patients. However, no histological findings, such as mast cell density or degree of inflammation, can be used as a preoperative predictor of treatment results. The best results of cystoplasty seem to be achieved in patients who have a small bladder capacity, determined preoperatively under anesthesia. Approximately 10%–20% of patients may not be able to void spontaneously after surgery and require self-catheterization. Because of the unpredictable results, cystoplasty must be recommended with caution for certain patients. There is no evidence to indicate that a supratrigonal cystectomy and substitution cystoplasty offer a therapeutic advantage over augmentation cystoplasty alone. The choice of bowel segment does not affect the final outcome provided that it is tubularized and made spherical in configuration.
Keywords:Augmentation enterocystoplasty  Intractable interstitial cystitis
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号